[go: up one dir, main page]

UA91028C2 - Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса - Google Patents

Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса

Info

Publication number
UA91028C2
UA91028C2 UAA200703392A UAA200703392A UA91028C2 UA 91028 C2 UA91028 C2 UA 91028C2 UA A200703392 A UAA200703392 A UA A200703392A UA A200703392 A UAA200703392 A UA A200703392A UA 91028 C2 UA91028 C2 UA 91028C2
Authority
UA
Ukraine
Prior art keywords
lavender oil
asthenia
neuro
stress
treatment
Prior art date
Application number
UAA200703392A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ангелика Динель
Михаэль Нельднер
Original Assignee
Др. Вильмар Швабе Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35448025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA91028(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Др. Вильмар Швабе Гмбх Унд Ко. Кг filed Critical Др. Вильмар Швабе Гмбх Унд Ко. Кг
Publication of UA91028C2 publication Critical patent/UA91028C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Данное изобретение касается профилактического и терапевтического использования лавандового масла для лечения посттравматического стресса, а также медикаментов, диетических пищевых продуктов, которые содержат лавандовое масло для перорального приема.
UAA200703392A 2004-10-06 2005-10-05 Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса UA91028C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004048716A DE102004048716A1 (de) 2004-10-06 2004-10-06 Verwendung von Lavendelöl zur Prophylaxe und Behandlung von Neurasthenie, Somatisierungsstörungen und von anderen stress-assoziierten Erkrankungen

Publications (1)

Publication Number Publication Date
UA91028C2 true UA91028C2 (ru) 2010-06-25

Family

ID=35448025

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200703392A UA91028C2 (ru) 2004-10-06 2005-10-05 Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса

Country Status (16)

Country Link
US (1) US20080124410A1 (ru)
EP (1) EP1796702B1 (ru)
JP (1) JP4900962B2 (ru)
KR (1) KR101291338B1 (ru)
CN (1) CN101068557B (ru)
AT (1) ATE447963T1 (ru)
AU (1) AU2005291420B2 (ru)
BR (1) BRPI0516545A (ru)
CA (1) CA2582993C (ru)
DE (2) DE102004048716A1 (ru)
ES (1) ES2333141T3 (ru)
MX (1) MX2007004104A (ru)
PT (1) PT1796702E (ru)
RU (1) RU2406521C2 (ru)
UA (1) UA91028C2 (ru)
WO (1) WO2006037629A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2553625C2 (ru) * 2013-10-02 2015-06-20 Дмитрий Александрович Никифоров Эфирно-масляная композиция "биозащита" для лечения астенического синдрома у больных с дисциркуляторной энцефалопатией

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2946775A1 (de) 2014-05-20 2015-11-25 LTS LOHMANN Therapie-Systeme AG Lavendelöl enthaltendes transdermales therapeutisches System
PL2974733T3 (pl) * 2014-07-14 2017-09-29 Dr. Willmar Schwabe Gmbh & Co. Kg Połączenie wyciągu z korzenia kozłka lekarskiego i olejku lawendowego do zastosowania w leczeniu zaburzeń snu
JP7164973B2 (ja) * 2018-06-12 2022-11-02 エスエス製薬株式会社 錠剤組成物
DE202019101081U1 (de) 2019-02-25 2019-04-29 Tim Farkas Lavendelkaugummi
DE102020117395A1 (de) * 2020-07-01 2022-01-05 Happygum G.m.b.H Zusammensetzung verwendet als stimmungsregulierendes Stimulans
IT202200010973A1 (it) 2022-05-25 2023-11-25 Cristalfarma S R L Composizione a base di erbali per uso nel trattamento della depressione post-partum

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3820666A1 (de) * 1988-06-18 1989-12-21 Friedrich Wilhelm Kosick Knoblauchzubereitung mit stark geruchsvermindernder wirkung
JPH1025246A (ja) * 1996-07-11 1998-01-27 Kobayashi Pharmaceut Co Ltd 催眠剤、催眠性飲食物及び催眠性餌料
DE59800447D1 (de) * 1997-06-21 2001-03-01 Bad Neuenahr Ag Packung auf Basis von Fango und Verfahren zur Herstellung derselben
GB2355189B (en) * 1999-08-20 2004-07-28 Yousef Haik Babikian Herbal preparation for the treatment of diabetes mellitus
US6582736B2 (en) * 2001-03-23 2003-06-24 Terra De Sol Therapeutic oil composition
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
JP2005500345A (ja) * 2001-08-03 2005-01-06 ファルマシア・アンド・アップジョン・カンパニー ５−ｈｔ６受容体親和性を有する５−アリールスルホニルインドール
RU2228039C1 (ru) * 2002-09-18 2004-05-10 Орловский государственный технический университет Способ хранения сосисок в натуральных и искусственных проницаемых оболочках
JP2005029513A (ja) * 2003-07-07 2005-02-03 Kobayashi Pharmaceut Co Ltd 口息清涼剤およびその製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2553625C2 (ru) * 2013-10-02 2015-06-20 Дмитрий Александрович Никифоров Эфирно-масляная композиция "биозащита" для лечения астенического синдрома у больных с дисциркуляторной энцефалопатией

Also Published As

Publication number Publication date
WO2006037629A1 (de) 2006-04-13
KR101291338B1 (ko) 2013-07-31
RU2406521C2 (ru) 2010-12-20
ES2333141T3 (es) 2010-02-17
CA2582993A1 (en) 2006-04-13
CA2582993C (en) 2013-08-20
JP4900962B2 (ja) 2012-03-21
EP1796702A1 (de) 2007-06-20
DE102004048716A1 (de) 2006-04-20
RU2007116726A (ru) 2008-11-20
JP2008515833A (ja) 2008-05-15
ATE447963T1 (de) 2009-11-15
CN101068557B (zh) 2016-05-11
DE502005008500D1 (de) 2009-12-24
MX2007004104A (es) 2007-06-14
EP1796702B1 (de) 2009-11-11
KR20070074580A (ko) 2007-07-12
PT1796702E (pt) 2009-11-20
BRPI0516545A (pt) 2008-09-09
AU2005291420B2 (en) 2012-03-29
US20080124410A1 (en) 2008-05-29
AU2005291420A1 (en) 2006-04-13
CN101068557A (zh) 2007-11-07

Similar Documents

Publication Publication Date Title
TW200640499A (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
EP1478371A4 (en) METHOD AND PRODUCTS FOR IMPROVING IMMUNE RESPONSES WITH IMIDAZOCHINOLINE COMPOUNDS
EP2213684A3 (en) Nogo-a antibodies for the treatment of Alzheimer disease
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
UA104988C2 (ru) Производные пирониндола и способ их получения
MXPA05012810A (es) Formas de dosis oral de memantina.
TW200738228A (en) Neramexane modified release matrix tablet
TW200621765A (en) Substituted phenylaminothiazoles and their use
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
YU84503A (sh) Upotreba azitromicina za pripremanje leka za lečenje neinfektivnih inflamatornih oboljenja
NZ778223A (en) Modified release tablet formulations containing phosphodiesterase inhibitors
MX2023001014A (es) Composiciones farmaceuticas que comprenden venglustat.
WO2007080116A3 (en) Use of cns penetrating anticancer compounds for the treatment of protozan diseases
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
MX2024014216A (es) Compuestos aromaticos que contienen boro y analogos de insulina relacionados
MXPA06014182A (es) Nucleosidos de 3-??-d-ribofuranosiltiazolo[4,5-d]piridimina y usos de los mismos.
UA91028C2 (ru) Использование лавандового масла для профилактики и лечения соматических расстройств и посттравматического стресса
TW200612903A (en) Use of trisubstituted benzopyranones
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
TW200501946A (en) Pharmaceutical composition for the treatment of schizophrenia in a patient with overweight
IL168308A (en) Compositions containing roflumilast and formoterol